BridgeBio Pharma, Inc. (BBIO) Profit Margin
BridgeBio Pharma, Inc. (BBIO) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | -642.47% |
| 2020-12-31 | -5439.74% |
| 2021-12-31 | -806.90% |
| 2022-12-31 | -619.70% |
| 2023-12-31 | -6913.92% |
| 2024-12-31 | -241.44% |
| 2025-12-31 | -144.39% |
How BBIO compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | -102.02% |
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
| IOVA | Iovance Biotherapeutics Inc. | -148.39% |
| SNDX | Syndax Pharmaceuticals Inc. | -165.60% |
| AQST | Aquestive Therapeutics Inc. | -188.09% |
These are five companies in the same sector as BBIO with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BridgeBio Pharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("BBIO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BBIO | $82.94 | -1.20% | 2.03M |
| 3 | ||||
| 4 | ||||
| 5 |